Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 158
9
Diseases
19
Unique genes
0.192
Avg. similarity score
Blindness
Most-connected disease (5 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Blindness
Cerebelloparenchymal disorder
Lactic acidosis
Normal pressure hydrocephalus
Ptosis
AIPL1-related retinopathy
Aica-ribosiduria
LCA5-related retinopathy
spermatogenic failure 19
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Blindness | 5 | 5 | 14 |
| Cerebelloparenchymal disorder | 4 | 4 | 1 |
| Lactic acidosis | 4 | 4 | 1 |
| Normal pressure hydrocephalus | 4 | 4 | 2 |
| Ptosis | 3 | 3 | 5 |
| AIPL1-related retinopathy | 1 | 1 | 1 |
| Aica-ribosiduria | 1 | 1 | 1 |
| LCA5-related retinopathy | 1 | 1 | 1 |
| spermatogenic failure 19 | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| PMPCA | 5 / 9 | Blindness, Cerebelloparenchymal disorder, Lactic acidosis, Normal pressure hydrocephalus and 1 more |
| AIPL1 | 2 / 9 | AIPL1-related retinopathy, Blindness |
| ATIC | 2 / 9 | Aica-ribosiduria, Blindness |
| CFAP43 | 2 / 9 | Normal pressure hydrocephalus, spermatogenic failure 19 |
| LCA5 | 2 / 9 | Blindness, LCA5-related retinopathy |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| The canonical retinoid cycle in rods (twilight vision) | Reactome | 3 / 20 | 94.8× | 3.76e-6 | 1.51e-4 ✓ sig. |
| Activation of the phototransduction cascade | Reactome | 1 / 9 | 70.2× | 1.42e-2 | 8.41e-2 |
| Opsins | Reactome | 1 / 10 | 63.2× | 1.57e-2 | 8.96e-2 |
| Purine ribonucleoside monophosphate biosynthesis | Reactome | 1 / 12 | 52.7× | 1.88e-2 | 9.94e-2 |
| Passive transport by Aquaporins | Reactome | 1 / 12 | 52.7× | 1.88e-2 | 9.94e-2 |
| Retinoid cycle disease events | Reactome | 1 / 13 | 48.6× | 2.04e-2 | 1.04e-1 |
| Cushing syndrome | KEGG | 2 / 155 | 8.2× | 2.45e-2 | 1.15e-1 |
| Processing of SMDT1 | Reactome | 1 / 16 | 39.5× | 2.50e-2 | 1.17e-1 |
| VxPx cargo-targeting to cilium | Reactome | 1 / 21 | 30.1× | 3.27e-2 | 1.35e-1 |
| Cholesterol biosynthesis | Reactome | 1 / 21 | 30.1× | 3.27e-2 | 1.35e-1 |
| Phototransduction | KEGG | 1 / 29 | 21.8× | 4.49e-2 | 1.61e-1 |
| Antifolate resistance | KEGG | 1 / 30 | 21.1× | 4.64e-2 | 1.65e-1 |
| Inactivation, recovery and regulation of the phototransduction cascade | Reactome | 1 / 33 | 19.2× | 5.10e-2 | 1.73e-1 |
| One carbon pool by folate | KEGG | 1 / 38 | 16.6× | 5.85e-2 | 1.86e-1 |
| Molecules associated with elastic fibres | Reactome | 1 / 38 | 16.6× | 5.85e-2 | 1.86e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| visual perception | GO:0007601 | 7 / 215 | 32.0× | 1.08e-9 | 2.41e-7 ✓ sig. |
| photoreceptor cell maintenance | GO:0045494 | 4 / 45 | 87.4× | 1.11e-7 | 1.32e-5 ✓ sig. |
| phototransduction, visible light | GO:0007603 | 3 / 13 | 227× | 2.53e-7 | 2.65e-5 ✓ sig. |
| camera-type eye development | GO:0043010 | 4 / 74 | 53.2× | 8.39e-7 | 7.19e-5 ✓ sig. |
| response to light stimulus | GO:0009416 | 3 / 28 | 105× | 2.87e-6 | 1.92e-4 ✓ sig. |
| sensory perception of light stimulus | GO:0050953 | 2 / 13 | 151× | 7.59e-5 | 2.47e-3 ✓ sig. |
| retina homeostasis | GO:0001895 | 2 / 15 | 131× | 1.02e-4 | 3.07e-3 ✓ sig. |
| cerebrospinal fluid circulation | GO:0090660 | 2 / 18 | 109× | 1.48e-4 | 4.06e-3 ✓ sig. |
| retinal metabolic process | GO:0042574 | 2 / 19 | 104× | 1.66e-4 | 4.41e-3 ✓ sig. |
| retinoid metabolic process | GO:0001523 | 2 / 38 | 51.8× | 6.74e-4 | 1.17e-2 ✓ sig. |
| zeaxanthin biosynthetic process | GO:1901827 | 1 / 1 | 984× | 1.02e-3 | 1.52e-2 ✓ sig. |
| regulation of plasma membrane sterol distribution | GO:0097036 | 1 / 1 | 984× | 1.02e-3 | 1.52e-2 ✓ sig. |
| positive regulation of protein geranylgeranylation | GO:2000541 | 1 / 1 | 984× | 1.02e-3 | 1.52e-2 ✓ sig. |
| ciliary basal body-plasma membrane docking | GO:0097711 | 1 / 2 | 492× | 2.03e-3 | 2.28e-2 ✓ sig. |
| negative regulation of DNA methylation-dependent heterochromatin formation | GO:0090310 | 1 / 2 | 492× | 2.03e-3 | 2.28e-2 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Cerebelloparenchymal disorder | Lactic acidosis | 0.500 | 1 | 6.49e-5 | 2.34e-4 ✓ sig. |
| Cerebelloparenchymal disorder | Normal pressure hydrocephalus | 0.333 | 1 | 1.30e-4 | 3.90e-4 ✓ sig. |
| Lactic acidosis | Normal pressure hydrocephalus | 0.333 | 1 | 1.30e-4 | 3.90e-4 ✓ sig. |
| Normal pressure hydrocephalus | spermatogenic failure 19 | 0.333 | 1 | 1.30e-4 | 3.90e-4 ✓ sig. |
| Cerebelloparenchymal disorder | Ptosis | 0.167 | 1 | 3.25e-4 | 7.58e-4 ✓ sig. |
| Lactic acidosis | Ptosis | 0.167 | 1 | 3.25e-4 | 7.58e-4 ✓ sig. |
| Normal pressure hydrocephalus | Ptosis | 0.143 | 1 | 6.49e-4 | 1.22e-3 ✓ sig. |
| Aica-ribosiduria | Blindness | 0.067 | 1 | 9.09e-4 | 1.56e-3 ✓ sig. |
| AIPL1-related retinopathy | Blindness | 0.067 | 1 | 9.09e-4 | 1.56e-3 ✓ sig. |
| Blindness | Cerebelloparenchymal disorder | 0.067 | 1 | 9.09e-4 | 1.56e-3 ✓ sig. |
| Blindness | Lactic acidosis | 0.067 | 1 | 9.09e-4 | 1.56e-3 ✓ sig. |
| Blindness | LCA5-related retinopathy | 0.067 | 1 | 9.09e-4 | 1.56e-3 ✓ sig. |